Seegene, a leading PCR-based molecular diagnostic company, interviewed Dr. Marta del Pino, an expert in cervical cancer prevention, to discuss the value of HPV testing and genotyping in the new cervical cancer screening paradigm at EUROGIN 2023.

HPV is the most common sexually transmitted infection, with data showing that nearly all sexually active people will get at least one type of HPV at some point in their lives. While most infections cause no symptoms and improve without treatment within two years, some types of HPV can cause health problems such as genital warts and cancer.

Del Pino explains the difference between a Pap test and an HPV test; and discusses cervical cancer screening guidelines in Europe.

Read the GenomeWeb article to find out more!